NEW YORK (GenomeWeb) – Molecular diagnostics firm AltheaDx filed a preliminary prospectus on Monday with the US Securities and Exchange Commission for an initial public offering with a maximum aggregate offering price of $69 million.

The San Diego-based company has not yet priced its shares or said how many shares it plans to offer. It intends to list on the Nasdaq Global Market under ticker symbol "IDGX." Citigroup and Jefferies are the joint book-running managers on the proposed offering, and William Blair and Cantor Fitzgerald are the co-managers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.